 |
|
|
|
|
|
NEWS RELEASE:
FOR IMMEDIATE RELEASE:
|
Contact:
Jacques Cornet, VP of Business Development & Strategic Marketing
Cedara Software Corp.
905.672.2100 x-2564 jacques.cornet@cedara.com
|
|
Media Contact:
Beth Frost-Johnson, Sr. VP of Marketing
Merge Healthcare
(414) 977-4254
bethfj@merge.com
|
|
Version française de communiqué de presse
Attention: Business/Financial Editors:
FRENCH HOSPITAL ASSOCIATION, GIP CPAGE SELECTS CEDARA SOFTWARE AS ITS EXCLUSIVE ELECTRONIC PATIENT RECORD (EPR) PARTNER
Toronto, ON, May 17, 2006 – Cedara Software, a Merge Healthcare company (Nasdaq: MRGE; TSX: MRG) and a leading independent developer of medical software technologies for the global healthcare market, today announced that GIP CPAGE, a public hospital association in France, has selected Cedara Software as its exclusive Electronic Patient Record (EPR) partner. Cedara Software was selected following a highly competitive tender process and a vote by its public hospital members.
GIP CPAGE is a public Information Technology Group in France that has developed an administrative Hospital Information System (HIS), which has been implemented in a large number of its 250 public hospital affiliates. GIP CPAGE provides over arching information technology guidance and administrative support to its affiliated hospitals, including small institutions and large multi site facilities.
Cedara aXigate™ complements GIP CPAGE’s HIS and together provides a complete administrative and clinical hospital information solution. Cedara aXigate has already been integrated with GIP CPAGE’s HIS and is currently installed at one of the largest GIP CPAGE member hospitals, University Hospital of Besançon (CHU), a 1200 bed hospital network. "Our Selection Committee is impressed and convinced by the clinical capabilities and modern architecture of Cedara aXigate,” said Gilles Leger, Managing Director of GIP CPAGE. “Cedara aXigate provides highly complimentary EPR functionality to our existing HIS offering, and allows our member hospitals to leverage their existing clinical information systems without costly replacement. We are looking forward to working closely with Cedara, a worldwide software leader in the healthcare industry."
Many hospitals have a number of existing clinical and information systems in use. Cedara aXigate’s unique interoperability capabilities allow hospitals to add modern EPR functionality without replacing legacy systems.
Cedara aXigate is a leading edge, fully secure, fully web-based solution for patient, medical and clinical process management. Cedara aXigate employs an open architecture, built with XML, Java and AJAX that incorporates information from labs, radiology, the pharmacy and other divergent areas into the hospital database. With components for patient registration, consultation, reporting, prescription, follow-up and codification, Cedara aXigate provides a folder-based approach to medical information management, displaying relevant information at the click of a button to different health care professionals. Specialists can utilize Cedara aXigate’s variety of modules designed to incorporate clinical content into the patient database, including Oncology, Psychiatry, Radiology, Surgery, Neurology, Anesthesiology, OB/GYN and more. The unique clinical content can be stored and accessed through a standard interface that provides a comprehensive portrait of medical images, diagnosis and test results.
"We are very pleased to have been selected by GIP CPAGE, a major player in the Hospital IT landscape," said Brian Pedlar, President of Cedara Software. “The combination of C.Page’s Hospital Information System and Cedara aXigate will provide a comprehensive and cost-effective solution for managing the needs of healthcare facilities throughout France. We look forward to offering the aXigate solution to C.Page’s public hospitals as they go through their electronic patient record selection process."
###
Cedara Software is a Merge Healthcare company focused on the development of custom engineered software applications and development tools for the medical imaging OEM and International markets. Cedara software is deployed in hospitals and clinics worldwide and is licensed by many of the world's leading medical device and healthcare information technology companies. Cedara technologies and expertise span all the major digital imaging modalities including computed tomography (CT), magnetic resonance imaging (MRI), digital X-ray, mammography, ultrasound, echo-cardiology, angiography, nuclear medicine, positron emission tomography (PET) and fluoroscopy. Cedara medical imaging offerings are used in all aspects of clinical imaging workflow including the capture of a patient's digital image; the archiving, communication and manipulation of digital images; sophisticated clinical applications to analyze digital images; and the use of imaging in minimally-invasive surgery. For additional information, visit our website at www.cedara.com.
Merge Healthcare is a market leader in the development and delivery of medical imaging and information management software and services. With over twenty years of leadership in the medical imaging and healthcare information technology markets, Merge Healthcare provides innovative solutions for both OEM and the end-user healthcare markets. We custom engineer clinical and imaging applications and development tools that are on the forefront of medicine and its use of medical imaging for OEM and international customers. We develop innovative medical imaging software solutions that support end-to-end business and clinical workflow for radiology department and specialty practices, imaging centers and hospitals. Our innovative software solutions use leading-edge imaging software technologies that accelerate market delivery for our OEM customers, while our end-user solutions improve our customers' productivity and enhance the quality of patient care they provide. For additional information, visit our website at www.merge.com.
All trademarks appearing in this release are the property of Cedara Software Corp. and/or Merge Healthcare.
|
Attn: Beth Frost-Johnson
Merge Healthcare
6737 West Washington St.
Suite 2250
Milwaukee, WI 53214
|
|
|
|
|
|
| Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, the forward-looking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company's inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company's inability to meet the requirements of The NASDAQ Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.
|
|
|
